See also this year's filing and all EDGAR filings for this company.
PDF Report 0001369786_2016_Sagent_Pharmaceuticals_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001369786, Sagent Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 191,592,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 78,350,000 |
| 2 | PropertyPlantAndEquipmentNet | 19,761,000 |
| 3 | remainder_Assets | 60,029,000 |
| 4 | LiabilitiesCurrent | 83,655,000 |
| 5 | LiabilitiesNoncurrent | 2,963,000 |
| 6 | remainder_Liabilities | 12,021,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 53,204,507 |
| 9 | ResearchAndDevelopmentExpense | 31,013,670 |
| 10 | remainder_Expenses | 272,002,641 |
| 11 | remainder_Revenues | 334,457,355 |
| 12 | remainder_NetIncome | -2,224,318 |
| 13 | remainder_ComprehensiveNetIncome | -65,237,128 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 349,732,000 |
| 1 | Liabilities | 98,639,000 |
| 2 | Expenses | 356,220,818 |
| 3 | Revenues | 334,457,355 |
| 4 | StockholdersEquity | 251,093,000 |
| 5 | NetIncome | -23,987,781 |
| 6 | ComprehensiveNetIncome | -56,606,345 |
| 7 | BaseVar | 603,255,310 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.19 |
| 9 | EconomicCapitalRatio | 3.15 |
Edgar->Model Mapping
Feature Distribution
Change over Time
